C. Morimoto

C. Morimoto, M. Sakamoto, Taketo Yamada, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.

Terry L. Smith, Maria A. Rodriguez, P. Mclaughlin, 2003, Oncology reports.

Knockdown of XAB 2 Enhances All-Trans Retinoic Acid – Induced Cellular Differentiation in All-Trans Retinoic Acid – Sensitive and – Resistant Cancer Cells

T. Morio, M. Nagasawa, E. Verdin, 2007 .

Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.

T. Morio, M. Nagasawa, E. Verdin, 2007, Cancer research.

IL-12 Responsiveness and Expression of IL-12 Receptor in Human Peripheral Blood Monocyte-Derived Dendritic Cells

Katsuaki Sato, K. Tadokoro, S. Asano, 2000, The Journal of Immunology.

Monocyte-Derived Dendritic Cells IL-12 Receptor in Human Peripheral Blood IL-12 Responsiveness and Expression of Juji

Katsuaki Sato, K. Tadokoro, S. Asano, 2000 .

Effector memory CD4+T cells in mesenteric lymph nodes mediate bone loss in food-allergic enteropathy model mice, creating IL-4 dominance

S. Nakamura, H. Kiyono, C. Morimoto, 2021, Mucosal Immunology.

Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction.

C. Morimoto, A. Komiyama, K. Agematsu, 1998, Blood.

Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans.

K. Anderson, D. Williams, D. Chauhan, 1992, Blood.

Tyrosine Phosphorylation of Crk-associated Substrates by Focal Adhesion Kinase

K. Kamiguchi, S. Iwata, H. Fujita, 1997, The Journal of Biological Chemistry.

Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines.

C. Morimoto, K. Ohnuma, N. Dang, 2010, Biochemical and biophysical research communications.

Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody

B. Bosch, S. Iwata, C. Morimoto, 2013, Journal of Virology.

CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma

Y. Takeshima, V. Amatya, C. Morimoto, 2012, Clinical Cancer Research.

Interleukin-12 induces tyrosine phosphorylation of an 85-kDa protein associated with the interleukin-12 receptor beta 1 subunit.

C. Morimoto, T. Kitamura, Y. Nojima, 1998, Cellular immunology.

An adult case of Henoch-Schönlein purpura complicating common peroneal nerve mononeuropathy

C. Morimoto, K. Ohnuma, N. Oyaizu, 2009, Modern rheumatology.

Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells

L. Poellinger, Y. Makino, C. Morimoto, 2003 .

Negative regulation of the hypoxia-inducible transcription factors by IPAS defines a novel anti-angiogenesis therapeutic strategy

L. Poellinger, Y. Makino, C. Morimoto, 2003, Arthritis Research & Therapy.

Caveolin‐1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma

Y. Takeshima, V. Amatya, C. Morimoto, 2009, Histopathology.

CD134L Engagement Enhances Human B Cell Ig Production: CD154/CD40, CD70/CD27, and CD134/CD134L Interactions Coordinately Regulate T Cell-Dependent B Cell Responses1

Yuetsu Tanaka, C. Morimoto, H. Yagita, 2000, The Journal of Immunology.

Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin.

Kazuya Sato, C. Morimoto, K. Ohnuma, 2005, Cancer research.

Lymphocytes CD4 T + CD26 + Disease by IL-26 Regulation of Pulmonary Graft-versus-Host

T. Aune, S. Iwata, C. Morimoto, 2015 .

Regulation of Pulmonary Graft-versus-Host Disease by IL-26+CD26+CD4 T Lymphocytes

T. Aune, S. Iwata, C. Morimoto, 2015, The Journal of Immunology.

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma

Y. Takeshima, V. Amatya, C. Morimoto, 2012, Oncology reports.

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma

M. Okada, Y. Ohe, C. Morimoto, 2021, JTO clinical and research reports.

Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue

S. Iwata, C. Morimoto, K. Ohnuma, 2014, Diagnostic Pathology.

Influence of CD26 and integrins on the antigen sensitivity of human memory T cells.

C. Morimoto, F. Falcioni, Z. Nagy, 1996, Human immunology.

HTLV-I Tax induces and associates with Crk-associated substrate lymphocyte type (Cas-L)

S. Iwata, C. Morimoto, Takahiro Sasaki, 2005, Oncogene.

Role of Crk-associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans.

Y. Okada, S. Iwata, C. Morimoto, 2003, Arthritis and rheumatism.

Functional and phenotypic studies of Japanese adult T cell leukemia cells.

E. Reinherz, C. Morimoto, Hiromitsu Tanaka, 1985, The Journal of clinical investigation.

Src kinase plays an essential role in integrin-mediated tyrosine phosphorylation of Crk-associated substrate p130Cas.

Y. Yazaki, S. Aizawa, C. Morimoto, 1996, Biochemical and biophysical research communications.

Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors.

C. Morimoto, K. Ohnuma, N. Dang, 2013, Diabetes research and clinical practice.

Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis

T. Aune, S. Iwata, C. Morimoto, 2019, mAbs.

(MERS-CoV) Infection by Anti-CD26 Monoclonal Antibody

B. Bosch, S. Iwata, C. Morimoto, 2013 .

Bilateral Entry and Release of Middle East Respiratory Syndrome Coronavirus Induces Profound Apoptosis of Human Bronchial Epithelial Cells

C. Morimoto, C. Peters, T. Ksiazek, 2013, Journal of Virology.

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice

Y. Terauchi, C. Morimoto, Yuzuru Ito, 2011, Diabetes.

Cardiomyocyte-Specific Overexpression of HEXIM1 Prevents Right Ventricular Hypertrophy in Hypoxia-Induced Pulmonary Hypertension in Mice

C. Morimoto, K. Fukuda, H. Ojima, 2012, PloS one.

Establishment of anti-mesothelioma monoclonal antibodies

C. Morimoto, O. Hino, R. Hatano, 2016, BMC Research Notes.

Direct association of adenosine deaminase with a T cell activation antigen, CD26.

C. Morimoto, Y. Nojima, Chika Morimoto, 1993, Science.

CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions

C. Morimoto, K. Ohnuma, N. Dang, 2021, Cureus.

Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation.

S. Iwata, C. Morimoto, K. Ohnuma, 2004, Blood.

Association of CD 26 with CD 45 RA outside lipid rafts attenuates cord blood T-cell activation

S. Iwata, C. Morimoto, K. Ohnuma, 2004 .

CD27/CD70 interaction contributes to the activation and the function of human autoreactive CD27+ regulatory T cells.

S. Iwata, C. Morimoto, S. Jacquot, 1997, Cellular immunology.

CD27-CD70 interactions regulate B-cell activation by T cells.

C. Morimoto, K. Agematsu, S. Jacquot, 1995, Proceedings of the National Academy of Sciences of the United States of America.

CD27/CD70 interaction directly induces natural killer cell killing activity

C. Morimoto, A. Komiyama, T. Mori, 1996, Immunology.

Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27.

G. Freeman, C. Morimoto, K. Agematsu, 1994, Journal of immunology.

Direct demonstration of the CD27 molecule involved in the negative regulatory effect on T cell activation.

C. Morimoto, S. Schlossman, T. Tanaka, 1993, Cellular immunology.

Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes

H. Young, C. Morimoto, J. Ortaldo, 1995, European journal of immunology.

CD26: a key molecule in immune regulation and autoimmune diseases

C. Morimoto, K. Ohnuma, N. Dang, 2003, Modern rheumatology.

Good or evil: CD26 and HIV infection.

C. Morimoto, H. Tsuda, H. Tsuda, 2000, Journal of dermatological science.

Negative regulation of the anti‐human immunodeficiency virus and chemotactic activity of human stromal cell‐derived factor 1α by CD26/dipeptidyl peptidase IV

C. Morimoto, T. Shioda, O. Hosono, 1998, FEBS letters.

The tetraspanin CD9 is preferentially expressed on the human CD4+CD45RA+ naive T cell population and is involved in T cell activation

S. Iwata, C. Morimoto, N. Dang, 2004, Clinical and experimental immunology.

The role of CD26/dipeptidyl peptidase IV in cancer.

C. Morimoto, K. Ohnuma, N. Dang, 2008, Frontiers in bioscience : a journal and virtual library.

Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target

C. Morimoto, K. Ohnuma, N. Dang, 2017, Current Medicinal Chemistry.

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition

C. Morimoto, M. Sakamoto, Taketo Yamada, 2016, Cancer Cell International.

Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.

S. Iwata, C. Morimoto, N. Dang, 2012, Biochemical and biophysical research communications.

Identification of cancer stem cell markers in human malignant mesothelioma cells.

S. Iwata, C. Morimoto, Taketo Yamada, 2011, Biochemical and biophysical research communications.

Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors

C. Morimoto, K. Ohnuma, N. Dang, 2007, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine CD 26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma

Y. Takeshima, V. Amatya, C. Morimoto, 2012 .

Distinctive signaling pathways through CD82 and β1 integrins in human T cells

S. Iwata, C. Morimoto, Takahiro Sasaki, 2002, European journal of immunology.

The 4F9 antigen is a member of the tetra spans transmembrane protein family and functions as an accessory molecule in T cell activation and adhesion.

G. Freeman, C. Morimoto, K. Tachibana, 1993, Cellular immunology.

Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma

C. Morimoto, K. Ohnuma, Taketo Yamada, 2014, PloS one.

CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells.

S. Iwata, Y. Ikeda, C. Morimoto, 2009, Biochemical and biophysical research communications.

Comparative Study of Regulatory T Cell Function of Human CD25+CD4+ T Cells from Thymocytes, Cord Blood, and Adult Peripheral Blood

C. Morimoto, T. Uchiyama, K. Ohnuma, 2008, Clinical & developmental immunology.

CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation.

C. Morimoto, K. Agematsu, T. Kobata, 1994, Journal of immunology.

CD27/CD70 interaction directly drives B cell IgG and IgM synthesis

C. Morimoto, A. Komiyama, K. Agematsu, 1995, European journal of immunology.

Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages.

K. Tadokoro, C. Morimoto, T. Juji, 2001, International immunology.

Systemic Lupus Erythematosus: Delineation of Subpopulations by Clinical, Serologic, and T Cell Subset Analysis

E. Reinherz, C. Morimoto, E. Penner, 1985, The American journal of the medical sciences.

Crosslinking CD3 with CD2 using sepharose-immobilized antibodies enhances T lymphocyte proliferation.

P. Anderson, C. Morimoto, M. Blue, 1988, Cellular immunology.

T-cell activation via CD26 and caveolin-1 in rheumatoid synovium

C. Morimoto, H. Inoue, K. Ohnuma, 2006, Modern rheumatology.

Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line.

C. Morimoto, D. Rothstein, A. Yamada, 1991, Journal of immunology.

Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.

C. Morimoto, D. Fox, J. Doshi, 1993, International immunology.

Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110.

G. Rice, J. Pober, A. Freedman, 1990, Science.

CD4CD45R cells are preferentially activated through the CD2 pathway

P. Anderson, C. Morimoto, J. Daley, 1988, European journal of immunology.

B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

J. Gribben, G. Freeman, A. Freedman, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Restoration of T-cell function in aged mice with long-term administration of levamisole.

C. Morimoto, M. Homma, T. Abe, 1979, Clinical immunology and immunopathology.

CD4+CD45RA+ and CD4+CD45RA- T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with Con A.

C. Morimoto, J. Daley, D. Rothstein, 1990, Cellular immunology.

Intestinal epithelial cells express and secrete the CD43 glycoform that contains core 2 O-glycans.

T. Irimura, C. Morimoto, J. Amano, 2001, Microbes and infection.

Regulatory interactions between members of the immunoglobulin superfamily.

P. Anderson, C. Morimoto, Chika Morimoto, 1988, Immunology today.

Adhesion of follicular lymphoma cells to lymphoid germinal centers--a potential mechanism of tumor cell homing following autologous transplantation.

A. Freedman, C. Morimoto, L. Nadler, 1994, Leukemia & lymphoma.

Follicular non-Hodgkin's lymphoma cell adhesion to normal germinal centers and neoplastic follicles involves very late antigen-4 and vascular cell adhesion molecule-1.

A. Freedman, C. Morimoto, L. Nadler, 1992, Blood.

Dual‐label immunocytochemistry of the active multiple sclerosis lesion: Major histocompatibility complex and activation antigens

C. Morimoto, T. Hayashi, J. Burks, 1988, Annals of neurology.

Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.

H. Weiner, D. Hafler, N. Letvin, 1987, The New England journal of medicine.

Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.

A. Steinberg, C. Morimoto, J. Daley, 1988, The Journal of clinical investigation.

A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.

N. Letvin, A. Steinberg, C. Morimoto, 1987, The Journal of clinical investigation.

Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.

E. Reinherz, A. Steinberg, C. Morimoto, 1984, The Journal of clinical investigation.

Structure of CD26 (dipeptidyl peptidase IV) and function in human T cell activation.

M. Hegen, C. Morimoto, S. Schlossman, 1997, Advances in experimental medicine and biology.

Role of the β1 integrin molecule in T-cell activation and migration

S. Iwata, C. Morimoto, H. Kobayashi, 2000, Modern rheumatology.

A Novel Form of Dipeptidylpeptidase IV Found in Human Serum.

C. Morimoto, J. Duke-Cohan, Chika Morimoto, 1995, The Journal of Biological Chemistry.

Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.

S. Iwata, C. Morimoto, K. Ohnuma, 2002, Cellular immunology.

Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.

C. Morimoto, J. Duke-Cohan, S. Schlossman, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

C. Morimoto, S. Schlossman, T. Tanaka, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.

C. Morimoto, J. Daley, N. Dang, 1990, Journal of immunology.

1F7, a novel cell surface molecule, involved in helper function of CD4 cells.

N. Letvin, G. Levinson, C. Morimoto, 1989, Journal of immunology.

The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions.

H. Weiner, D. Hafler, R. Sobel, 1988, Journal of immunology.

Optimal stimulation for CD70 induction on human monocyte‐derived dendritic cells and the importance of CD70 in naive CD4+ T‐cell differentiation

N. Kadowaki, S. Iwata, C. Morimoto, 2010, Immunology.

CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1.

S. Iwata, C. Morimoto, K. Ohnuma, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Soluble CD26/Dipeptidyl Peptidase IV Induces T Cell Proliferation Through CD86 Up-Regulation on APCs1

S. Iwata, C. Morimoto, K. Ohnuma, 2001, The Journal of Immunology.

Histamine H1‐receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases

S. Iwata, C. Morimoto, K. Ohnuma, 2009, Clinical and experimental immunology.

In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus.

A. Steinberg, C. Morimoto, S. Schlossman, 1983, The Journal of clinical investigation.

Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.

P. Anderson, C. Morimoto, D. Fox, 1988, The American journal of medicine.

Suppressor T cell function in patients with rheumatoid arthritis complicated by vasculitis.

C. Morimoto, T. Takeuchi, O. Hosono, 1984, Arthritis and rheumatism.

Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple sclerosis

H. Weiner, D. Hafler, C. Morimoto, 1988, Annals of neurology.

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage

T. Honjo, A. Nomoto, C. Morimoto, 1998 .

Response patterns of purified myeloma cells to hematopoietic growth factors.

C. Morimoto, B. Barut, Chika Morimoto, 1989, Blood.

Human Naive CD4+ T Cells to CCL3 and Associated with the Hyporesponsiveness of and a Deficiency of CCR5 Expression Are Event CCR1-Mediated Downstream Signaling An Abortive Ligand-Induced Activation of

Katsuaki Sato, C. Morimoto, H. Kawasaki, 2013 .

An Abortive Ligand-Induced Activation of CCR1-Mediated Downstream Signaling Event and a Deficiency of CCR5 Expression Are Associated with the Hyporesponsiveness of Human Naive CD4+ T Cells to CCL3 and CCL51

Katsuaki Sato, C. Morimoto, H. Kawasaki, 2002, The Journal of Immunology.

CCL 5 T Cells to CCL 3 and + Human Naive CD 4 Associated with the Hyporesponsiveness of and a Deficiency of CCR 5 Expression Are EventCCR 1-Mediated Downstream Signaling

Katsuaki Sato, C. Morimoto, H. Kawasaki, 2002 .

Chemokine Receptor Expressions and Responsiveness of Cord Blood T Cells

Katsuaki Sato, K. Tadokoro, C. Morimoto, 2001, The Journal of Immunology.

Responsiveness of Cord Blood T Cells Chemokine Receptor Expressions and

Katsuaki Sato, K. Tadokoro, C. Morimoto, 2022 .

CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling.

S. Iwata, C. Morimoto, S. Jacquot, 1997, Journal of immunology.

Cross‐linking of VLA/CD29 molecule has a co‐mitogenic effect with anti‐CD3 on CD4 cell activation in serum‐free culture system

C. Morimoto, N. Dang, A. Yamada, 1991, European journal of immunology.

CD26 expression on T cell lines increases SDF-1-α-mediated invasion

C. Morimoto, K. Ohnuma, N. Dang, 2009, British Journal of Cancer.

Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells.

C. Morimoto, J. Lambert, S. Schlossman, 1988, The Journal of clinical investigation.

Aberrant responsiveness to RANTES in synovial fluid T cells from patients with rheumatoid arthritis.

C. Morimoto, N. Hisakawa, Hirotoshi Tanaka, 2002, The Journal of rheumatology.

Prevention of acute graft‐versus‐host disease by humanized anti‐CD26 monoclonal antibody

C. Morimoto, K. Ohnuma, N. Dang, 2013, British journal of haematology.

Blockade of CD26-mediated T cell costimulation with soluble caveolin-1-Ig fusion protein induces anergy in CD4+T cells.

C. Morimoto, K. Ohnuma, N. Dang, 2009, Biochemical and biophysical research communications.

DISSECTION OF HUMAN IMMUNOREGULATORY T LYMPHOCYTES: IMPLICATIONS FOR UNDERSTANDING CLINICAL DISEASE

E. Reinherz, C. Morimoto, S. Meuer, 1983 .

Chapter 1 – Use of Monoclonal Antibodies in the Study of Autoimmunity and Immunodeficiency1

E. Reinherz, C. Morimoto, S. Schlossman, 1983 .

Activation of Human Monocytes for Enhanced Production of Interleukin 8 During Transendothelial Migration in Vitro

U. Ikeda, K. Shimada, C. Morimoto, 2004, Journal of Clinical Immunology.

CD26‐mediated co‐stimulation in human CD8+ T cells provokes effector function via pro‐inflammatory cytokine production

C. Morimoto, K. Ohnuma, N. Dang, 2013, Immunology.

Subpopulations of the T4+ inducer T cell subset in man: evidence for an amplifier population preferentially expressing Ia antigen upon activation.

E. Reinherz, C. Morimoto, S. Schlossman, 1981, Journal of immunology.

Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphoma.

C. Morimoto, N. Dang, H. Nishida, 2007, Biochemical and biophysical research communications.

Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex

C. Morimoto, K. Yamada, S. Akiyama, 1989, The Journal of experimental medicine.

Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin

C. Morimoto, K. Ohnuma, N. Oyaizu, 2010, Rheumatology International.

Cross-linking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes.

C. Morimoto, P. Anderson, M. Blue, 1987, Journal of immunology.

Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.

N. Letvin, C. Morimoto, J. Duke-Cohan, 1994, Proceedings of the National Academy of Sciences of the United States of America.

CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions.

C. Morimoto, T. Hirose, D. Rothstein, 1992, Journal of immunology.

CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin‐8 and RANTES

D. Taub, H. Young, C. Morimoto, 1995, European journal of immunology.

Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.

T. Aune, H. Naito, C. Morimoto, 2019, The Journal of investigative dermatology.

CD26 Mediates Dissociation of Tollip and IRAK-1 from Caveolin-1 and Induces Upregulation of CD86 on Antigen-Presenting Cells

S. Iwata, C. Morimoto, K. Ohnuma, 2005, Molecular and Cellular Biology.

Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5

M. Kitagawa, C. Morimoto, C. Nakaseko, 2008, Hematology.

CD26-Mediated Induction of EGR2 and IL-10 as Potential Regulatory Mechanism for CD26 Costimulatory Pathway

S. Iwata, C. Morimoto, K. Okumura, 2015, The Journal of Immunology.

Costimulatory Pathway forIL-10 as Potential Regulatory Mechanism CD 26-Mediated Induction of EGR 2 and Chikao

S. Iwata, C. Morimoto, K. Okumura, 2014 .

blood T-cell activation Association of CD26 with CD45RA outside lipid rafts attenuates cord

S. Iwata, C. Morimoto, K. Ohnuma, 2013 .

The human immunoregulatory T cell circuit: recent progress and its clinical implications.

C. Morimoto, S. Schlossman, 1987, The Keio journal of medicine.

Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.

E. Reinherz, C. Morimoto, J. Daley, 1982, Journal of immunology.

Anti-Human CD9 Fab Fragment Antibody Blocks the Extracellular Vesicle-Mediated Increase in Malignancy of Colon Cancer Cells

C. Morimoto, D. Tai, D. Corbeil, 2022, Cells.

Direct demonstration of the function of T cell subsets reactive with anti-T cell antibodies from SLE sera

E. Reinherz, C. Morimoto, S. Schlossman, 1982, Rheumatology International.

Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations.

E. Reinherz, C. Morimoto, S. Meuer, 1983, Journal of immunology.

Studies of Anti‐Lymphocyte Antibody in Patients with Active SLE

C. Morimoto, M. Homma, T. Abe, 1980, Scandinavian journal of immunology.

T‐large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition

Kazuya Sato, A. Barrett, C. Morimoto, 2003, British journal of haematology.

Briefdefinitive Report Identification of the Sequence Required for Expression of the 2h4 Epitope on the Human Leukocyte Common Antigens

H. Saito, C. Morimoto, M. Streuli, 2022 .

Strategic targeting of the glucocorticoid receptor for anti-inflammation

C. Morimoto, Hirotoshi Tanaka, N. Shimizu, 2007 .

Dipeptidyl peptidase in autoimmune pathophysiology.

C. Morimoto, K. Ohnuma, N. Dang, 2011, Advances in clinical chemistry.

Immunodeficiency associated with loss of T4+ inducer T-cell function.

E. Reinherz, R. Geha, F. Rosen, 1981, The New England journal of medicine.

Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol triggered suppressor T-cells.

C. Morimoto, Chika Morimoto, R. Kalish, 1989, The Journal of investigative dermatology.

Urushiol (poison ivy)-triggered suppressor T cell clone generated from peripheral blood.

C. Morimoto, R. Kalish, 1988, The Journal of clinical investigation.

Antilymphocyte antibodies and systemic lupus erythematosus.

C. Morimoto, S. Schlossman, C. Morimoto, 1987, Arthritis and rheumatism.

The Development of Monoclonal Antibodies against Human Immunoregulatory T Cell Subsets: The Isolation of Human Suppressor Inducer T Cell Subset

N. Letvin, C. Morimoto, S. Schlossman, 1986 .

The cellular basis for the induction of antigen‐specific T8 suppressor cells

N. Letvin, C. Morimoto, S. Schlossman, 1986, European journal of immunology.

Functional Differences of Anti‐T‐Cell Antibody in Patients with Systemic Lupus Erythematosus and Ulcerative Colitis

H. Asakura, C. Morimoto, T. Takeuchi, 1983, Scandinavian journal of immunology.

Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis.

E. Reinherz, A. Steinberg, C. Morimoto, 1981, The Journal of clinical investigation.

Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.

E. Reinherz, P. Schur, A. Steinberg, 1980, The Journal of clinical investigation.

Targeting of an Activated Tce l l Subset Using a Bispecific Antibody-Toxin Conjugate Directed Against CD 4 and CD 26

C. Morimoto, J. Duke-Cohan, 2022 .

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.

T. Honjo, A. Nomoto, C. Morimoto, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma

S. Iwata, C. Morimoto, T. Yamada, 2014, British Journal of Cancer.

CD26+ T cells in the pathogenesis of asthma

C. Morimoto, K. Ohnuma, T. Yamochi, 2005, Clinical and experimental immunology.

Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.

C. Morimoto, K. Ohnuma, N. Dang, 2018, Biochemical and biophysical research communications.

Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.

S. Iwata, C. Morimoto, T. Inukai, 2011, Biochemical and biophysical research communications.

CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO

C. Morimoto, K. Ohnuma, N. Dang, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.

C. Morimoto, N. Dang, É. Vivier, 1991, Journal of immunology.

CD11 molecule defines two types of suppressor cells within the T8+ population.

C. Morimoto, S. Schlossman, M. DiMaggio, 1988, Cellular immunology.

Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction.

J. Mallol, C. Lluis, R. Franco, 2002, The Biochemical journal.

Ligation of VLA-4 on T cells stimulates tyrosine phosphorylation of a 105-kD protein

C. Morimoto, D. Rothstein, Y. Nojima, 1992, The Journal of experimental medicine.

B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients.

C. Morimoto, Y. Tanaka, F. Tron, 2001, International immunology.

Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.

T. Mimori, C. Morimoto, N. Dang, 2002, The Journal of rheumatology.

Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells.

N. Letvin, C. Morimoto, N. Dang, 1991, Journal of immunology.

Comparison of Two Commercial ELISAs against an In‐House ELISA for Measuring Soluble CD26 in Human Serum

S. Iwata, C. Morimoto, K. Ohnuma, 2015, Journal of clinical laboratory analysis.

Up-Regulation on APCs Induces T Cell Proliferation Through CD86 Soluble CD26/Dipeptidyl Peptidase IV

C. Morimoto, K. Ohnuma, N. Dang, 2001 .

This information is current as Up-Regulation on APCs Induces T Cell Proliferation Through CD 86 Soluble CD 26 / Dipeptidyl Peptidase IV

S. Iwata, C. Morimoto, K. Ohnuma, 2001 .

VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin

M. Humphries, A. Mould, C. Morimoto, 1990, The Journal of experimental medicine.

Internalization of CD 26 by mannose 6-phosphate y insulin-like growth factor II receptor contributes to T cell activation

S. Iwata, C. Morimoto, Hirotoshi Tanaka, 2000 .

Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals.

T. Homma, C. Morimoto, A. Iwamoto, 1999, Clinical immunology.

Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.

S. Iwata, C. Morimoto, Takahiro Sasaki, 2005, The Journal of rheumatology.

Ebastine inhibits T cell migration, production of Th2‐type cytokines and proinflammatory cytokines

S. Iwata, C. Morimoto, N. Dang, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

factors Response patterns of purified myeloma cells to hematopoietic growth

C. Morimoto, B. Barut, P. Leavitt, 2011 .

Enhancement of lymphocyte response to PHA by lysosomal enzymes from polymorphonuclear leukocytes of RA joint fluid

C. Morimoto, M. Homma, T. Abe, 1980, Inflammation.

A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus.

C. Morimoto, K. Ohnuma, N. Dang, 2017, Journal of dermatological science.

beta1 integrins on human B cells Stimulation of tyrosine phosphorylation after ligation of beta7 and

A. Freedman, C. Morimoto, S. Manié, 2011 .

Stimulation of Tyrosine Phosphorylation After Ligation of p 7 and pl Integrins on Human B Cells

Jichun Chen, C. Morimoto, S. Manié, 2002 .

Cross‐linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen‐activated protein kinase

M. Hegen, C. Morimoto, S. Schlossman, 1997, Immunology.

CD26: an expanding role in immune regulation and cancer.

C. Morimoto, N. Dang, 2002, Histology and histopathology.

Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation.

C. Morimoto, C. Rudd, S. Schlossman, 1989, Molecular immunology.

Decrease of suppressor inducer (cd4+ 2h4+) t cells in multiple sclerosis cerebrospinal fluid

H. Weiner, D. Hafler, C. Morimoto, 1989, Annals of neurology.

Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells.

T. Homma, C. Morimoto, R. Mukasa, 1999, International immunology.

Activation of T cells through a T cell-specific epitope of CD45.

C. Morimoto, N. Dang, D. Rothstein, 1992, Cellular immunology.

Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine phosphatase activity in T cells

C. Morimoto, D. Rothstein, M. Streuli, 1990, European journal of immunology.

The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens

C. Morimoto, C. Rudd, Chika Morimoto, 1987, The Journal of experimental medicine.

The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system.

C. Morimoto, Chika Morimoto, S. Schlossman, 1987, Cellular immunology.

Lymphocyte Activation: Modulatory Effects Mediated by Interactions between Cell Adhesion Molecules

P. Anderson, C. Morimoto, M. Streuli, 1988, Annals of the New York Academy of Sciences.

Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.

C. Morimoto, J. Duke-Cohan, S. Schlossman, 1996, Journal of immunology.

CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells

S. Iwata, C. Morimoto, K. Ohnuma, 2014, PloS one.

Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts

C. Morimoto, D. Abraham, C. Denton, 2016, Biochemistry and biophysics reports.

Effect of H1‐receptor antagonists on proliferative response, cytokine production, and cellular migration of human T cells and macrophages

S. Iwata, C. Morimoto, K. You, 2008 .

CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299.

C. Morimoto, K. Ohnuma, N. Dang, 2005, Cancer research.

Large Cell Lymphoma Karpas 299 Extracellular Matrix , and Tumorigenicity of T-Anaplastic , Adhesion to 1 β Dependent Phosphorylation of Integrin − CD 26 Regulates p 38 Mitogen-Activated Protein Kinase

C. Morimoto, K. Ohnuma, N. Dang, 2005 .

Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint.

G. Mills, F. Cabanillas, C. Morimoto, 2001, Cancer research.

In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.

G. Mills, F. Cabanillas, J. Abbruzzese, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

M Checkpoint 2 Cell Cycle Arrest at the G Enzyme Activity Enhances Sensitivity to Doxorubicin-induced Expression of CD 26 and Its Associated Dipeptidyl Peptidase IV Updated

F. Cabanillas, C. Morimoto, K. Ohnuma, 2001 .

In Vitro and in Vivo Antitumor Effect of the Anti-CD 26 Monoclonal Antibody 1 F 7 on Human CD 30 1 Anaplastic Large Cell T-Cell Lymphoma Karpas 2991

G. Mills, F. Cabanillas, J. Abbruzzese, 2001 .

Expression of CD 26 and Its Associated Dipeptidyl Peptidase IV Enzyme Activity Enhances Sensitivity to Doxorubicin-induced Cell Cycle Arrest at the G 2 / M Checkpoint 1

G. Mills, Kazuya Sato, F. Cabanillas, 2001 .

Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function.

M. Hegen, D. Cho, C. Morimoto, 1998, Molecular immunology.

1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.

C. Morimoto, J. Daley, N. Dang, 1991, Journal of immunology.

Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation.

J. Ritz, R. Soiffer, C. Morimoto, 1994, The Journal of clinical investigation.

CD45 isoforms associated with distinct functions of CD4 cells derived from unusual healthy donors lacking CD45RA- T lymphocytes.

C. Morimoto, D. Rothstein, A. Yamada, 1991, Cellular immunology.

CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors

C. Morimoto, K. Ohnuma, N. Dang, 2003, British Journal of Cancer.

The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and anti-CD29 (4B4) antibodies.

C. Morimoto, D. Rothstein, S. Schlossman, 1990, Cellular immunology.

[Beta 1 integrin molecule and its immunoregulatory function of T cells].

C. Morimoto, 1999, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells

N. Letvin, C. Morimoto, C. Rudd, 1987, Nature.

Role of the VLA-4 molecule in T cell costimulation. Identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4.

C. Morimoto, K. Tachibana, Y. Nojima, 1995, Journal of immunology.

Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens.

C. Morimoto, M. Streuli, Chika Morimoto, 1988, Journal of immunology.

Modulation of immunological responses and amelioration of collagen-induced arthritis by the novel roxithromycin derivative 5-I

S. Iwata, C. Morimoto, K. Ohnuma, 2015, Modern rheumatology.

Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family

C. Morimoto, N. Dang, S. Schlossman, 1990, The Journal of experimental medicine.

Immunohistochemical Analysis of Suppressor‐Inducer and Helper‐Inducer T Cells in Multiple Sclerosis Brain Tissue

H. Weiner, D. Hafler, R. Sobel, 1988 .

Leukemia Relapse Mice from Acute Graft-versus-Host Disease TRAIL-Transduced Dendritic Cells Protect

Katsuaki Sato, C. Morimoto, M. Baba, 2005 .

Rapid inhibitory effect of tacrolimus on T cell migration by suppressing CD29-related functions.

C. Morimoto, Y. Munakata, T. Saito, 2004, Clinical and experimental rheumatology.

Stimulation of protein tyrosine phosphorylation in human B cells after ligation of the beta 1 integrin VLA-4.

A. Freedman, C. Benjamin, C. Morimoto, 1993, Journal of immunology.

Activation of human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor.

T. Nikaido, C. Morimoto, A. Yamada, 1991, Journal of immunology.

DPP8 is a novel therapeutic target for multiple myeloma

T. Kondo, C. Morimoto, K. Arita, 2019, Scientific Reports.

Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma.

Y. Ohe, C. Morimoto, Y. Kaneko, 2019, Lung cancer.

Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens

S. Iwata, C. Morimoto, K. Ohnuma, 2019, PloS one.

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

G. Zalcman, C. Morimoto, P. Vielh, 2017, British Journal of Cancer.

CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells.

S. Iwata, C. Morimoto, K. Ohnuma, 2014, Biochemical and biophysical research communications.

Anti-CD26 Monoclonal Antibody–Mediated G1-S Arrest of Human Renal Clear Cell Carcinoma Caki-2 Is Associated with Retinoblastoma Substrate Dephosphorylation, Cyclin-Dependent Kinase 2 Reduction, p27kip1 Enhancement, and Disruption of Binding to the Extracellular Matrix

S. Iwata, C. Morimoto, M. Tachibana, 2006, Clinical Cancer Research.

Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors

G. Mills, C. Morimoto, K. Ohnuma, 2003, British Journal of Cancer.

Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro.

C. Morimoto, W. Cruikshank, J. Berman, 1992, Journal of immunology.

Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies.

C. Morimoto, N. Dang, Chika Morimoto, 1992, Molecular immunology.

Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.

C. Morimoto, N. Dang, S. Schlossman, 1990, Journal of immunology.

Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7

S. Iwata, Hirofumi Tanaka, C. Morimoto, 2007, Oncogene.

Characteristics of anti-T-cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies.

E. Reinherz, C. Morimoto, S. Schlossman, 1980, Clinical immunology and immunopathology.

Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130Cas‐related docking protein family, and its subsequent binding to the Src homology 2 domain of c‐Crk

Y. Yazaki, C. Morimoto, T. Nakamoto, 1997, European journal of immunology.

CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation.

C. Morimoto, N. Dang, D. Rothstein, 1992, Journal of immunology.

Atlas of Genetics and Cytogenetics in Oncology and Haematology DPP 4 ( dipeptidyl-peptidase 4 )

C. Morimoto, K. Ohnuma, 2013 .

Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen.

C. Morimoto, C. Rudd, T. Tedder, 1989, Cellular immunology.

Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody

S. Iwata, G. Zalcman, C. Morimoto, 2020, Biomarker Research.

Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation.

J. Ritz, R. Soiffer, C. Morimoto, 1995, Blood.

Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus.

E. Reinherz, A. Steinberg, C. Morimoto, 1982, Clinical immunology and immunopathology.

Peripheral blood T-lymphocytes during the course of systemic lupus erythematosus.

C. Morimoto, M. Homma, T. Abe, 1975, The Keio journal of medicine.

Development of an antigen-specific CD8 suppressor effector clone in man.

C. Morimoto, S. Schlossman, T. Takeuchi, 1988, Journal of immunology.

Human T lymphocyte populations which bind to P- or E-selectin are enriched with cells expressing core 2 O-glycans.

K. Nishioka, T. Homma, C. Morimoto, 1999, Immunology letters.

In Vitro TNP‐Specific Antibody Formation by Peripheral Lymphocytes from Patients with Systemic Lupus Erythematosus

C. Morimoto, M. Homma, T. Abe, 1977, Scandinavian journal of immunology.

Studies of Anti‐lymphocyte Antibody of Patients with Active SLE

C. Morimoto, M. Homma, T. Abe, 1979, Scandinavian journal of immunology.

The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells.

N. Letvin, C. Morimoto, C. Rudd, 1986, Journal of immunology.

Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects.

S. Iwata, C. Morimoto, N. Dang, 2010, Journal of ethnopharmacology.

Cytomegalovirus (CMV) retinitis and CMV antigenemia as a clue to impaired adrenocortical function in patients with AIDS

S. Oka, C. Morimoto, Tetsuya Nakamura, 1997, AIDS.

Generation of CD8 (T8) cytotoxic cells has a preferential requirement for CD4+2H4- inducer cells.

C. Morimoto, S. Schlossman, R. Kalish, 1988, Cellular immunology.

The isolation and characterization of the human helper inducer T cell subset.

N. Letvin, C. Morimoto, A. Boyd, 1985, Journal of immunology.

Molecular Interactions, T‐Cell Subsets and a Role of the CD4/CD8:p56lck Complex in Human T‐Cell Activation

P. Anderson, C. Morimoto, C. Rudd, 1989, Immunological reviews.

Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.

M. Hegen, C. Morimoto, Y. Xu, 1996, Journal of immunology.

Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26/DPPIV.

Y. Kamikubo, C. Morimoto, K. Ohnuma, 2021, The Journal of allergy and clinical immunology.

Effects of repetitive transcranial magnetic stimulation on ER stress-related genes and glutamate, γ-aminobutyric acid and glycine transporter genes in mouse brain

C. Morimoto, Satoru Kobayashi, T. Ikeda, 2018, Biochemistry and biophysics reports.

Selective modulation of glucocorticoid receptor function toward development of novel antiinflammation: lessons from a phenylpyrazolosteroid cortivazol

C. Morimoto, Hirotoshi Tanaka, N. Shimizu, 2004, Modern rheumatology.

VLA-4-mediated signaling.

S. Iwata, C. Morimoto, K. Tachibana, 1998, Current topics in microbiology and immunology.

MICAL, a Novel CasL Interacting Molecule, Associates with Vimentin*

S. Ogawa, C. Morimoto, K. Tachibana, 2002, The Journal of Biological Chemistry.

Communicative interactions between subpopulations of human T lymphocytes required for generation of suppressor effector function in a primary antibody response.

E. Reinherz, C. Morimoto, S. Schlossman, 1982, Journal of immunology.

A novel mechanism for imatinib mesylate (STI571) resistance in CML cell line KT-1: role of TC-PTP in modulating signals downstream from the BCR-ABL fusion protein.

S. Iwata, M. Kizaki, Y. Miyakawa, 2004, Experimental hematology.

Protein kinase A-mediated phosphorylation of the T-cell surface antigen CD27.

C. Morimoto, K. Agematsu, Y. Nojima, 1993, Immunology.

Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus.

A. Steinberg, C. Morimoto, S. Schlossman, 1989, Arthritis and rheumatism.

Reactivity of inducer cell subsets and T8-cell activation during the human autologous mixed lymphocyte reaction.

E. Reinherz, C. Morimoto, J. Daley, 1984, Clinical immunology and immunopathology.

Altered function of suppressor T lymphocytes in patients with active systemic lupus erythematosus--in vitro immune response to autoantigen.

C. Morimoto, M. Homma, T. Abe, 1979, Clinical immunology and immunopathology.

Transcriptional Up-regulation of Inhibitory PAS Domain Protein Gene Expression by Hypoxia-inducible Factor 1 (HIF-1)

L. Poellinger, Y. Makino, C. Morimoto, 2007, Journal of Biological Chemistry.

Hypoxia-Inducible Factor Regulates Survival of Antigen Receptor-Driven T Cells 1

Y. Okada, Hiroshi Nakamura, L. Poellinger, 2003, The Journal of Immunology.

of Antigen Receptor-Driven T Cells Hypoxia-Inducible Factor Regulates Survival

Yasunori, Hiroshi Nakamura, L. Poellinger, 2003 .

Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer

S. Iwata, C. Morimoto, M. Sakamoto, 2012, Clinical Cancer Research.

Suppression of NF‐κB‐dependent gene expression by a hexamethylene bisacetamide‐inducible protein HEXIM1 in human vascular smooth muscle cells

H. Handa, Y. Makino, C. Morimoto, 2003, Genes to cells : devoted to molecular & cellular mechanisms.

SHP-2 inhibits tyrosine phosphorylation of Cas-L and regulates cell migration.

S. Iwata, C. Morimoto, N. Dang, 2009, Biochemical and biophysical research communications.

Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthritis synovial fluid: expression on human T cells with transendothelial migratory activity.

S. Iwata, T. Homma, C. Morimoto, 2001, Arthritis and rheumatism.

Altered tyrosine phosphorylation via the very late antigen (VLA)/beta1 integrin stimulation is associated with impaired T-cell signaling through VLA-4 after allogeneic bone marrow transplantation.

J. Ritz, R. Soiffer, C. Morimoto, 1997, Blood.

CD27 and CD40 Inhibit p53-independent Mitochondrial Pathways in Apoptosis of B Cells Induced by B Cell Receptor Ligation*

C. Morimoto, H. Hase, H. Kojima, 2002, The Journal of Biological Chemistry.

CD26 expression is attenuated by TGF‐β and SDF‐1 autocrine signaling on stromal myofibroblasts in human breast cancers

Y. Miyagi, C. Morimoto, O. Hino, 2019, Cancer medicine.

Tissue- and context-dependent modulation of hormonal sensitivity of glucocorticoid-responsive genes by hexamethylene bisacetamide-inducible protein 1.

H. Handa, M. Suematsu, C. Morimoto, 2008, Molecular endocrinology.

Role of the hinge region of glucocorticoid receptor for HEXIM1-mediated transcriptional repression.

S. Iwata, C. Morimoto, K. Fukuda, 2008, Biochemical and biophysical research communications.

P. Rambotti Lecture. Human naive and memory T cells revisited: new markers (CD31 and CD27) that help define CD4+ T cell subsets.

C. Morimoto, S. Schlossman, 1993, Clinical and experimental rheumatology.

Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle.

Keiichi Fukuda, Makoto Suematsu, Hirotoshi Tanaka, 2011, Cell metabolism.

The Cellular Basis of Impaired T Lymphocyte Functions in the Elderly

C. Morimoto, M. Homma, T. Abe, 1980, Journal of the American Geriatrics Society.

Beta 1-integrin-mediated cell signaling in T lymphocytes.

K. Kamiguchi, S. Iwata, C. Morimoto, 2000, Journal of dermatological science.

Cas-L Is Required for β1 Integrin-Mediated Costimulation in Human T Cells

K. Kamiguchi, S. Iwata, C. Morimoto, 1999, The Journal of Immunology.

Cas-L is required for beta 1 integrin-mediated costimulation in human Tcells.

K. Kamiguchi, S. Iwata, C. Morimoto, 1999, Journal of immunology.

Structure and function of Cas-L, a 105-kD Crk-associated substrate- related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes

S. Iwata, M. Minegishi, C. Morimoto, 1996, The Journal of experimental medicine.

Hapten-specific carrier-dependent tolerance induction in man in vitro.

C. Morimoto, Y. Borel, 1983, Cellular immunology.

Cellular interaction between subsets of T8 population for maximal suppression of antigen-specific antibody response.

E. Reinherz, C. Morimoto, S. Schlossman, 1984, Cellular immunology.

Tyrosine phosphorylation of Crk-associated substrate lymphocyte-type is a critical element in TCR- and beta 1 integrin-induced T lymphocyte migration.

K. Kamiguchi, S. Iwata, C. Morimoto, 1999, Journal of immunology.

Direct association of pp125FAK with paxillin, the focal adhesion- targeting mechanism of pp125FAK

C. Morimoto, K. Tachibana, Chika Morimoto, 1995, The Journal of experimental medicine.

Focal Adhesion Kinase (pp125FAK) Is Tyrosine Phosphorylated after Engagement of α4β1 and α5β1 Integrins on Human T-Lymphoblastic Cells

C. Morimoto, K. Tachibana, Y. Nojima, 1995 .

The role of Cas-L/NEDD9 as a regulator of collagen-induced arthritis in a murine model.

S. Iwata, C. Morimoto, K. Ohnuma, 2015, Biochemical and biophysical research communications.

Lymphocyte Migration Integrin-Induced T 1 b Element in TCR- and Substrate Lymphocyte-Type Is a Critical Tyrosine Phosphorylation of Crk-Associated

K. Kamiguchi, S. Iwata, C. Morimoto, 1999 .

IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells

T. Aune, C. Morimoto, K. Okumura, 2021, Cell Death & Disease.

Role of the Glucocorticoid Receptor for Regulation of Hypoxia-dependent Gene Expression*

Hiroshi Nakamura, Y. Makino, C. Morimoto, 2003, Journal of Biological Chemistry.

Cytokine Receptor Common β Subunit-mediated STAT5 Activation Confers NF-κB Activation in Murine proB Cell Line Ba/F3 Cells*

Sumiko Watanabe, Y. Makino, C. Morimoto, 2002, The Journal of Biological Chemistry.

Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation.

S. Iwata, C. Morimoto, T. Ishii, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.

S. Miyano, S. Imoto, M. Nagasaki, 2009, American journal of physiology. Endocrinology and metabolism.

Cd26/Dipeptidyl Peptidase IV in Context

S. Iwata, C. Morimoto, 1999, The Journal of experimental medicine.

Anti‐human CD9 antibody Fab fragment impairs the internalization of extracellular vesicles and the nuclear transfer of their cargo proteins

C. Morimoto, D. Corbeil, G. Rappa, 2019, Journal of cellular and molecular medicine.

Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines

C. Morimoto, K. Ohnuma, N. Dang, 2011, BMC Cancer.

CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders.

C. Morimoto, K. Ohnuma, N. Dang, 2007, Mini reviews in medicinal chemistry.

Comodulation of CXCR4 and CD26 in Human Lymphocytes*

J. Mallol, C. Lluis, R. Franco, 2001, The Journal of Biological Chemistry.

SS-A/Ro52, an Autoantigen Involved in CD28-Mediated IL-2 Production 1

S. Iwata, C. Morimoto, K. Ohnuma, 2003, The Journal of Immunology.

Evidence of Aberration of T‐cell Subsets in Aged Individuals

C. Morimoto, M. Homma, T. Abe, 1981, Scandinavian journal of immunology.

TGF-β1 Reciprocally Controls Chemotaxis of Human Peripheral Blood Monocyte-Derived Dendritic Cells Via Chemokine Receptors

Katsuaki Sato, K. Tadokoro, C. Morimoto, 2000, The Journal of Immunology.

Regulation of in vitro primary anti-DNP antibody production by functional subsets of T lymphocytes in man.

E. Reinherz, C. Morimoto, S. Schlossman, 1981, Journal of immunology.

Generation of antigen-specific suppressor cells in vitro in man.

E. Reinherz, C. Morimoto, S. Schlossman, 1983, Journal of immunology.

Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy

C. Morimoto, K. Ohnuma, N. Dang, 2018, Modern rheumatology.

Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect

Kohji Yamada, C. Morimoto, M. Sakamoto, 2009, Cancer Cell International.

CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells.

K. Tadokoro, C. Morimoto, T. Juji, 1999, Blood.

Humanized anti‐IL‐26 monoclonal antibody as a novel targeted therapy for chronic graft‐versus‐host disease

T. Aune, C. Morimoto, K. Ohnuma, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production

C. Morimoto, A. Komiyama, K. Agematsu, 1997, European journal of immunology.

TCR Engagement Increases Hypoxia-Inducible Factor-1α Protein Synthesis via Rapamycin-Sensitive Pathway under Hypoxic Conditions in Human Peripheral T Cells1

Hiroshi Nakamura, L. Poellinger, Y. Makino, 2005, The Journal of Immunology.

Peripheral T Cells under Hypoxic Conditions in Human Synthesis via Rapamycin-Sensitive Pathway Protein α Hypoxia-Inducible Factor-1 TCR Engagement Increases

Hiroshi Nakamura, L. Poellinger, Y. Makino, 2005 .

Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis

H. Aburatani, Y. Kadono, Sakae Tanaka, 2016, PloS one.

2H1--a novel antigen involved in T lymphocyte triggering.

N. Letvin, C. Morimoto, C. Rudd, 1988, Journal of immunology.

Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells.

J. Ritz, C. Morimoto, M. Robertson, 1992, Journal of immunology.

A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.

D. Watkins, N. Letvin, C. Morimoto, 1989, Disease markers.

Definition of the T-lymphocyte inducer of suppression in primates using a monoclonal antibody.

N. Letvin, C. Morimoto, S. Schlossman, 1985, Cellular immunology.

A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes

D. Watkins, N. Letvin, C. Morimoto, 1989, The Journal of experimental medicine.

Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies.

E. Reinherz, C. Morimoto, S. Schlossman, 1983, Journal of immunology.

The role of the macrophage in in vitro primary anti-DNP antibody production in man.

C. Morimoto, S. Schlossman, J. Distaso, 1981, Journal of immunology.

The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation.

J. Ritz, R. Soiffer, C. Morimoto, 1994, Transplantation.

The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.

N. Kadowaki, S. Iwata, C. Morimoto, 2009, International immunology.

Direct Associat ion o f pp 125 Fpa ~ with PaxiUin , the Focal Adhes ion-target ing Mechanism

C. Morimoto, K. Tachibana, N. D’Avirro, 2003 .

Direct Association of pp125 Fpa~ with PaxiUin, the Focal Adhesion-targeti ng Mechanism of pp125 F~a~

C. Morimoto, K. Tachibana, Toshiya Sato, 1995 .

Focal adhesion kinase (pp125FAK) is tyrosine phosphorylated after engagement of alpha 4 beta 1 and alpha 5 beta 1 integrins on human T-lymphoblastic cells.

C. Morimoto, K. Tachibana, Y. Nojima, 1995, Cellular immunology.

The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors.

C. Morimoto, D. Rothstein, M. Streuli, 1992, The Journal of biological chemistry.

The 1A4 molecule (CD27) is involved in T cell activation.

C. Morimoto, J. Daley, Y. Nojima, 1991, Journal of immunology.

Human antigen‐specific memory T cells express the homing receptor (LAM‐1) necessary for lymphocyte recirculation

C. Morimoto, T. Tedder, D. Rothstein, 1990, European journal of immunology.

Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomains.

S. Iwata, C. Morimoto, K. Ohnuma, 2016, Biochemical and biophysical research communications.

Activation of mitogen-activated protein kinase through α5/β1 integrin is required for cell cycle progression of B progenitor cell line, Reh, on human marrow stromal cells

G. Ishii, M. Kitagawa, C. Morimoto, 2000 .

Establishment of anti-mesothelioma monoclonal antibodies

C. Morimoto, O. Hino, R. Hatano, 2016, BMC Research Notes.

CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.

S. Iwata, C. Morimoto, S. Schlossman, 1999, International immunology.

Different Regulatory Effects of Pentoxifylline on Human T Cell Activation Pathways

C. Morimoto, S. Schlossman, Y. Umezawa, 1997, Journal of Clinical Immunology.

Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.

M. Hegen, D. Cho, C. Morimoto, 1997, Journal of immunology.

A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target.

C. Morimoto, K. Ohnuma, N. Dang, 2018, Frontiers in bioscience.

In Vitro Immune Response of SLE Lymphocytes

C. Morimoto, T. Takeuchi, M. Homma, 1982, Scandinavian journal of immunology.

The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.

C. Morimoto, Keiko Yamamoto, S. Yamada, 2005, Molecular endocrinology.

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

C. Morimoto, M. Sakamoto, Taketo Yamada, 2018, Blood Cancer Journal.

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies

C. Morimoto, M. Mizuguchi, N. Dang, 2023, Cells.

DNA-daunorubicin complexes specifically suppress in vitro spontaneous anti-DNA antibody production in lymphocytes of patients with systemic lupus erythematosus.

Y. Masuho, C. Morimoto, T. Takeuchi, 1986, Arthritis and rheumatism.

Cell-mediated immune response in idiopathic thrombocytopenic purpura. In vitro cellular response to autologous and homologous platelet and platelet membrane by macrophage inhibitory test.

C. Morimoto, M. Homma, T. Abe, 1977, Clinical immunology and immunopathology.

Cell-mediated immunity to platelets in SLE patients with thrombocytopenia: two different types of lymphocyte stimulation.

C. Morimoto, M. Homma, T. Abe, 1980, Clinical immunology and immunopathology.

Role of IL-26+CD26+CD4 T Cells in Pulmonary Chronic Graft-Versus-Host Disease and Treatment with Caveolin-1-Ig Fc Conjugate.

C. Morimoto, K. Ohnuma, N. Dang, 2016, Critical reviews in immunology.

CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells.

S. Iwata, C. Morimoto, N. Dang, 2009, Biochemical and biophysical research communications.

Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.

M. Wasik, C. Morimoto, 1990, Journal of immunology.

Strategies for specific immunomodulation in transplantation

C. Morimoto, 1994 .

HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.

H. Handa, C. Morimoto, M. Kusuhara, 2005, Proceedings of the National Academy of Sciences of the United States of America.

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

G. Zalcman, C. Morimoto, P. Vielh, 2017, British Journal of Cancer.

CD26 Expression on T-Anaplastic Large Cell Lymphoma (ALCL) Line Karpas 299 is associated with increased expression of Versican and MT1-MMP and enhanced adhesion

S. Iwata, C. Morimoto, K. Ohnuma, 2013, BMC Cancer.

Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.

Y. Takeshima, V. Amatya, C. Morimoto, 2011, Oncology reports.

SSA/Ro52 autoantigen interacts with Dcp2 to enhance its decapping activity.

C. Morimoto, K. Ohnuma, Hirotoshi Tanaka, 2008, Biochemical and biophysical research communications.

Human GM-CSF induces HIV-1 LTR by multiple signalling pathways.

K. Arai, Sumiko Watanabe, C. Morimoto, 2002, Biochimie.

Induces Profound Apoptosis of Human Respiratory Syndrome Coronavirus Bilateral Entry and Release of Middle East

C. Morimoto, T. Ksiazek, C. Tseng, 2014 .

Methodes d'identification d'agents immunoregulateurs, agents immunoregulateurs, et utilisations associees

C. Morimoto, K. Ohnuma, 2004 .

Tyrosine phosphorylation of the product of the c-cbl protooncogene is [corrected] induced after integrin stimulation.

R. Salgia, B. Druker, A. Freedman, 1997, Experimental hematology.

Stimulation of tyrosine phosphorylation after ligation of beta7 and beta1 integrins on human B cells.

A. Freedman, C. Morimoto, S. Manié, 1996, Blood.

Activation of mitogen-activated protein kinase through alpha5/beta1 integrin is required for cell cycle progression of B progenitor cell line, Reh, on human marrow stromal cells.

G. Ishii, M. Kitagawa, C. Morimoto, 2000, Experimental hematology.

Gene expression microarray data from mouse CBS treated with rTMS for 30 days, mouse cerebrum and CBS treated with rTMS for 40 days

C. Morimoto, Satoru Kobayashi, T. Ikeda, 2018, Data in brief.

Characteristic and functional specificity of anti-human BAT (brain associated thymocyte antigen) serum.

C. Morimoto, M. Homma, T. Abe, 1980, The Tohoku journal of experimental medicine.

Multiple effects of repetitive transcranial magnetic stimulation on neuropsychiatric disorders.

N. Nukina, C. Morimoto, S. Kitayama, 2013, Biochemical and biophysical research communications.

Human T cells can be directed to lyse tumor targets through the alternative activation/T11-E rosette receptor pathway.

C. Morimoto, J. Lambert, S. Schlossman, 1988, Journal of immunology.

Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes.

A. Steinberg, C. Morimoto, M. Homma, 1982, Journal of immunology.

The T4 molecule differentially regulating the activation of subpopulations of T4+ cells.

C. Morimoto, S. Schlossman, T. Takeuchi, 1987, Journal of immunology.

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

C. Morimoto, M. Sakamoto, Taketo Yamada, 2018, Blood Cancer Journal.

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition

C. Morimoto, M. Sakamoto, Taketo Yamada, 2016, Cancer Cell International.

Functional roles of CD26/DPP4 in bleomycin‐induced pulmonary fibrosis

S. Dudek, C. Morimoto, Y. Kasuya, 2023, Physiological reports.

Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70.

C. Morimoto, T. Hirose, K. Agematsu, 1995, Journal of immunology.

Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue

H. Weiner, D. Hafler, R. Sobel, 1987, Journal of Neuroimmunology.

Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.

J. Ritz, C. Morimoto, J. Lambert, 1989, Journal of immunology.

Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.

S. Iwata, C. Morimoto, T. Ishii, 2000, Arthritis and rheumatism.

In vitro anti-DNA antibody synthesis by peripheral blood lymphocytes in patients with systemic lupus erythematosus.

C. Morimoto, T. Takeuchi, M. Homma, 1981, Clinical immunology and immunopathology.

Requirement of Fas(CD95), CD45, and CD11a/CD18 in monocyte-dependent apoptosis of human T cells.

Z. Ao, M. Hegen, C. Morimoto, 1996, Journal of immunology.

Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29.

C. Morimoto, J. Duke-Cohan, S. Schlossman, 1993, Transplantation.

Beta 1 integrin-mediated signaling in human T cells.

C. Morimoto, K. Tachibana, 1996, Human Cell.

Selective inhibition of anti-nucleoside-specific antibody production by nucleoside-ricin A conjugate.

Y. Masuho, A. Steinberg, C. Morimoto, 1983, Journal of immunology.

Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.

S. Miyano, S. Imoto, M. Suematsu, 2009, American Journal of Physiology. Endocrinology and Metabolism.

Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5

M. Kitagawa, C. Morimoto, C. Nakaseko, 2008, Hematology.

A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes

D. Watkins, N. Letvin, C. Morimoto, 1989, The Journal of experimental medicine.

CD26: an expanding role in immune regulation and cancer.

C. Morimoto, Nam H. Dang, 2002, Histology and histopathology.

Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections

C. Morimoto, D. Abraham, C. Denton, 2016, Data in brief.

Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.

Y. Takeshima, V. Amatya, C. Morimoto, 2011, Oncology reports.

Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26.

C. Morimoto, J. Duke-Cohan, S. Schlossman, 1993, Blood.

Blockade of CD26 Signaling Inhibits Human Osteoclast Development

C. Morimoto, M. Sakamoto, Taketo Yamada, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.

N. Kadowaki, S. Iwata, C. Morimoto, 2009, International immunology.

Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody

B. Bosch, S. Iwata, C. Morimoto, 2013, Journal of Virology.

Human CD4 HelperT CellActivation : FunctionalInvolvementofTwo DistinctCollagen Receptors,1177and VLA IntegrinFamily

C. Morimoto, 1990 .

Could Serum Antibody to Poly(ADP‐Ribose) and/or Histone H1 Be Marker for Senile Dementia of Alzheimer Type?

C. Morimoto, H. Akatsu, Y. Kanai, 2007, Annals of the New York Academy of Sciences.

Cytokine receptor common beta subunit-mediated STAT5 activation confers NF-kappa B activation in murine proB cell line Ba/F3 cells.

Sumiko Watanabe, Y. Makino, C. Morimoto, 2002, The Journal of biological chemistry.